Combined hepatoprotective pharmacotherapy for liver disease
نویسندگان
چکیده
Fixed-dose drug products as well non-fixed hepatoprotective combinations are commonly used in modern clinical practice. Combined and concurrent use makes it possible to augment the pharmacological effects of individual agents, or extend range their potential indications. The drugs most considered for combination therapy include essential phospholipids, glycyrrhizinic acid, ursodeoxycholic silibinin, S-adenosylmethionine. This paper discusses rationale combined liver-targeting from a pathogenetic viewpoint, provides review evidence trials on pharmacotherapy liver disease.
منابع مشابه
Pharmacotherapy for Nonalcoholic Fatty Liver Disease.
Lifestyle modifications and optimization of the management of cardiometabolic comorbidities are currently the mainstay of treatment for patients with nonalcoholic fatty liver disease. Pharmacotherapy to halt or reverse hepatic histological injury and prevent the development of end-stage liver disease is specifically offered to patients with nonalcoholic steatohepatitis (NASH) and those with adv...
متن کاملA Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملCurrent and upcoming pharmacotherapy for non-alcoholic fatty liver disease.
Given the high prevalence and rising incidence of non-alcoholic fatty liver disease (NAFLD), the absence of approved therapies is striking. Although the mainstay of treatment of NAFLD is weight loss, it is hard to maintain, prompting the need for pharmacotherapy as well. A greater understanding of disease pathogenesis in recent years was followed by development of new classes of medications, as...
متن کاملCombined Pharmacotherapy and Psychotherapy for Depression.
Well, someone can decide by themselves what they want to do and need to do but sometimes, that kind of person will need some combined pharmacotherapy and psychotherapy for depression references. People with open minded will always try to seek for the new things and information from many sources. On the contrary, people with closed mind will always think that they can do it by their principals. ...
متن کاملCurrent pharmacotherapy for Alzheimer's disease.
Alzheimer's disease (AD) is an age-related neurodegenerative disease that affects approximately 4.5 million people in the United States. The mainstays of current pharmacotherapy for AD are compounds aimed at increasing the levels of acetylcholine in the brain, thereby facilitating cholinergic neurotransmission through inhibition of the cholinesterases. These drugs, known as acetylcholinesterase...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental & clinical gastroenterology
سال: 2022
ISSN: ['1682-8658']
DOI: https://doi.org/10.31146/1682-8658-ecg-203-7-5-20